Journal Watch 27/09/2023
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Journal Watch 27/09/2023
LuCI agent used for the treatment of obesity-associated metabolic disorders
SURPASS-4 trial: Tirzepatide slows rate of eGFR decline and reduces UACR in T2DM patients
SARS-CoV-2 infects fat tissue and creates inflammation
LIGHT-UP: GS200 may improve insulin sensitivity and positively impact metabolic syndrome
‘Personal fat threshold’ explains the development and remission of T2DM
ICER finds semaglutide more effective, but more expensive